Response and prognosis to neoadjuvant chemotherapy in women early breast cancer of HER2-low status
{{output}}
Objective: With the significant clinical benefits of antibody-coupled drugs (ADCs) against HER2, the HER2-low-expressing population has come into focus. HER2-low-expressing patients express this membrane protein despite the absen... ...
